期刊文献+

MKK4基因的抑癌及致癌作用 被引量:1

The Cancer Inhibition and Carcinogenicity of MKK4 Gene
下载PDF
导出
摘要 丝裂原活化蛋白激酶激酶4(MKK4)基因为新近发现的肿瘤转移抑制基因。其编码蛋白可激活c-Jun氨基端激酶和p38这两条丝裂原活化蛋白激酶通路,将细胞外刺激信号转导至细胞核内,引起细胞的增殖、分化、转化及凋亡。MKK4基因具有抑癌作用,随着MKK4基因启动子区Rs3826392(T/G)位点G变异个数增加,结肠癌、肺癌及鼻咽癌的患病率会随之降低。与之相反,MKK4基因同时具有致癌作用,其表达上调可能与胰腺癌、前列腺癌的发生及浸润转移有关。 The mitogen-activated protein kinase 4 (MKK4) gene is recently recognized as a novel metastasis suppressor gene. Its protein could activate both of c-Jun N-terminal kinase (JNK) and p38 mitogenactivated protein kinase induced mitogen-activated protein kinase (MAPK) cascade to transduce extracellular signal into nucleus, and induee eeU proliferation, differentiation, transformation and apoptosis. The MKK4 gene could inhibit cancer initiation. Several studies had showed the initiation of colon ,lung and nasopharynx eancer was reduced along with the number increase of G mutation on the MKK4 promoter region Rs3826392 (T/G) site. On the contrary,MKK4 may also have careinogenicity. Various studies suggested the up-regulating of MKK4 might be related to the initiation, invasion and metastasis of pancreatic cancer and prostate
出处 《医学综述》 2014年第17期3117-3119,共3页 Medical Recapitulate
关键词 肿瘤转移抑制基因 MKK4基因 抑癌 致癌 Tumor metastasis suppressor gene MKK4 geue Cancer suppressing Carcinogenic
  • 相关文献

参考文献28

  • 1Steeg PS,de la Rosa A, Flatow U, et al. Nm23 and breast cancer metastasis [ J ]i Breast CanCer Res Treat, 1993,25 (2) : 172-187.
  • 2Yoshida BA,Sokoloff MM, Welch DR, et al. Metastasis-suppressor genes:a review and perspective on an emerging field [ J]. J Nail Cancer Inst,2000,92 (21) . 717-1730.
  • 3Takekawa M, Tatebayashi K, Saito H. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases [ J]. Mol Ce11,2005,18 (3) : 295 -306.
  • 4Maruyama J, Naguro I, Takeda K, et al. Stress-activated MAP kinase cascades in cellular seneacence[ J]. Curr Med Chem,2009, 16(10) :1229-1235.
  • 5Owen GR, Achilonu I, Dirr HW. High yield purification of JNK113 and active by in vitro reconstitution of the MEKK1-MKK4-JNK- MAPK phosphorylation cascade [ J ]. Protein Expr Purif, 2013,87 (2) :87-99.
  • 6Das KC, Muniyappa H. c-Jun-NH2 terminal kinase (JNK) -media- tes AP-1 activation by thioredoxin : Phosphorylation of cJun, JunB, and Fra-1 [ J ]. Mol Cell Biochem ,2010,337 (1/2) :53-63.
  • 7Taylor JL, Szmulewitz RZ, Lotan T, et aL New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells[ ] ]. Cancer Letters ,2008,272 ( 1 ) : 12-22.
  • 8Brancho D, Tanaka N, Jaeschke A, et al. Mechanism of p38 MAP kinase activation in vivo [ J ]. Genes Dev ,2003 ,17 (16) : 1969-1978.
  • 9Finegan KG, Toumier C. The mitogen-activated protein kinases kinases 4 has a pro-oncogenic role in skin cancer[ J]. Cancer Res, 2010,70(14) :5797-5806.
  • 10Dolado I,Swat A ,Ajenjo N ,et al. p38oc MAP kinase as a sensor of reactive oxygen species in tumorigenesis [ J ]. Cancer Cell ,2007,11 (2) : 191-205.

二级参考文献27

  • 1王亚轩,蔡文清,黎玮,杨书文,李景东,霍红旭.人端粒酶逆转录酶启动子调控的重组腺病毒的构建及其在膀胱癌细胞中的表达[J].中华实验外科杂志,2007,24(7):850-852. 被引量:5
  • 2Whitmarsh A J,Davis RJ.Role of mitogen-activated protein kinase kinase 4 in cancer.Oncogene,2007,26:3172-3184.
  • 3Kim HL,Vander Griend DJ,Yang X,et al.Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.Cancer Res,2001,61:2833-2837.
  • 4Yamada SD,Hickson JA,Hrobowski Y,et al.Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.Cancer Res,2002,62:6717-6723.
  • 5Bost F,McKay R,Dean N,et al.The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells.J Biol Chem,1997,272:33422-33429.
  • 6Yoshida BA,Dubauskas Z,Chekmareva MA,et al.Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1),a prostate cancer metastasis suppressor gene encoded by human chromosome 17.Cancer Res,1999,59:5483-5487.
  • 7Tanoue T,Nishida E.Molecular recognitions in the MAP kinase cascades.Cell Signal,2003,15:455-462.
  • 8Dreissigacker U,Mueller MS,Unger M,et al.Oncogenic K-Ras downregulates Racl and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.Cell Signal,2006,18:1156-1168.
  • 9Bardwell L.Mechanisms of MAPK signalling specificity.Biochem Soc Trans,2006,34:837-841.
  • 10Fukazawa T,Matsuoka J,Yamatsuji T,et al.Adenovirus-mediated cancer gene therapy and virotherapy.Int J Mol Med,2010,25:3-10.

共引文献1

同被引文献11

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部